Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of roflumilast in COPD patients treated with tiotropium
2006-004508-37Phase 3Completed
- Sponsor
- Nycomed
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Roflumilast + tiotropium with Placebo + tiotropium (2 arms). Primary endpoint: Change in pre-dose pre-bronchodilator FEV1 over 24 weeks. Started Oct 2006; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-004508-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004508-37.